Results 161 to 170 of about 6,415,892 (312)

Additional file 2: of Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinsonâ s disease

open access: yes, 2015
Supplementary online material. (DOCX 119 kb)
Tamburrino, Anna   +11 more
openaire   +1 more source

Recent Advances in Transparent Microelectrode Device Architecture and Fabrication Strategies for Biomedical Applications

open access: yesAdvanced Materials Technologies, EarlyView.
Transparent microelectrode arrays enable simultaneous optical and electrical electrophysiology with high spatiotemporal resolution, allowing multimodal observations of dynamic biological systems. Advances in materials and device architectures improve device performance by addressing key trade‐offs between optical transparency, impedance, and ...
Michael Abraham Listyawan   +6 more
wiley   +1 more source

Driving impairment in patients with movement disorders: examining the Baylor driving questionnaire by objective driving assessment

open access: yesClinical Parkinsonism & Related Disorders
Background: The development of a screening tool to identify driving impairment in patients with movement disorders is an unmet need. Objective: To validate Baylor Driving Questionnaire for Movement Disorders (BDQMD) by objective driving assessment (ODA).
Abhishek Lenka   +5 more
doaj   +1 more source

Additional file 1: of Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinsonâ s disease

open access: yes, 2016
Institutional Review Boards or Independent Ethics Committees of participating sites in the PD0005 study. (PDF 220 kb)
Hauser, Robert   +6 more
openaire   +1 more source

UK Biobank Parkinson’s Disease Phenotype

open access: yes, 2019
UK Biobank Parkinson’s Disease ...
Kenan Direk (4588036)
core   +1 more source

Intelligent Micro/Nanorobots for Targeted Interventional Therapy: From Bench to Clinic

open access: yesAdvanced Robotics Research, EarlyView.
Zirui Zhang et al. reviewed the application and challenges of mobile nanomachines in interventional therapy. By converting exogenous energy, including chemical, magnetic, optical, and ultrasonic sources, into mechanical forces, micro/nanorobots (MNRs) enable precise actuation at unprecedented scales. Evolving far beyond traditional drug delivery, these
Zirui Zhang   +5 more
wiley   +1 more source

Parkinson's disease dementia: a neural networks perspective. [PDF]

open access: yes, 2015
In the long-term, with progression of the illness, Parkinson's disease dementia affects up to 90% of patients with Parkinson's disease. With increasing life expectancy in western countries, Parkinson's disease dementia is set to become even more ...
Gratwicke, J, Jahanshahi, M, Foltynie, T
core  

Global DNA methylation in Alzheimer’s disease and Parkinson’s disease

open access: yes, 2016
Global DNA methylation in Alzheimer’s disease and Parkinson’s ...
Asija Zaciragic (3545033)   +14 more
core   +1 more source

Cell‐Based Biohybrid Micro/Nanorobots for Biotherapy

open access: yesAdvanced Robotics Research, EarlyView.
This review systematically evaluates cell‐based biohybrid micro/nanorobots (CB‐BMRs), highlighting their cell selection criteria, fabrication strategies, and diverse actuation modes. Furthermore, it surveys the promising therapeutic applications of CB‐BMRs in targeted cancer, thrombosis, and inflammation treatments, while comprehensively discussing ...
Lin Wang   +11 more
wiley   +1 more source

Biomarkers for Parkinson’s Disease

open access: yes, 2011
Identifying much-needed biomarkers for detecting early Parkinson’s disease will accelerate drug development.
Todd B. Sherer
core   +1 more source

Home - About - Disclaimer - Privacy